Alliance Growers Corp. (CNSX:ACG) entered into an exclusive agreement to acquire Biotech Canna for CAD 8 million on January 2, 2018. As of January 25, 2018, terms were revised and as a result, Alliance Growers Corp. (CNSX:ACG) agreed to acquire Biotech Canna for CAD 7.3 million. As per the terms of merger, total consideration of CAD 8 million which will be paid in stages includes cash consideration of CAD 0.6 million and CAD 7.4 million in Alliance Growers shares out of which Alliance Growers is making an initial payment of CAD 0.1 million and CAD 0.15 million in stock. The final payment of CAD 0.5 million in Alliance stock to be released from escrow upon Health Canada Access to Cannabis for Medical Purposes Regulations approval. As of January 25, 2018, the consideration will include CAD 0.6 million and 7.4 million shares valued at a deemed price of CAD 1.00 per share. The consideration includes CAD 0.1 million cash plus 1.35 million shares on signing; 1.45 million shares released immediately at application approved for Ready to Build; CAD 0.5 million plus 1.2 million shares paid immediately at permits approved stage; 1.7 million shares released immediately at cultivation and 1.7 million shares released immediately at Health Canada ACMPR approval. The shares will be issued at the closing, and all but 1.35 million shares will be held in escrow and released in stages following completion of each of these milestones. As of April 20, 2018, Alliance Growers completed private placement of CAD 0.75 million, proceeds of which will be used to finance the transaction.